| Name | Fedora Optical Inc |
|---|---|
| Organization Name | Fedora Optical Inc |
| Location | 236 N Main St, Manchester, Connecticut 06042 |
| Type | Supplier |
| Phone | (860) 646-3577 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In people who have experienced a stroke, but who have no known history of coronary heart disease, beginning regular treatment with the cholesterol-lowering drug atorvastatin soon after the stroke can reduce the risk of recurrent stroke by 16 percent
At the largest green gathering in the South, chefs, foodies and restaurants have the opportunity to show off their organic food products to an audience deeply interested in green lifestyles and healthy, organic eating. At the 10th Annual Renewable Energy Roundup & Green Living Fair over 7500 people gather annually to explore products, organic food and technology that is sustainable, renewable, recyclable and geared to offering healthy, green-living choices.
Researchers at UCLA have identified a novel molecule in the brain that, after stroke, blocks the formation of new connections between neurons. As a result, it limits the brain's recovery. In a mouse model, the researchers showed that blocking this molecule-called ephrin-A5-induces axonal sprouting, that is, the growth of new connections between the brain's neurons, or cells, and as a result promotes functional recovery.
ChemAxon - a leading provider of cheminformatics software for the life sciences industry has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.
A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome, according to a pilot study conducted at the Icahn School of Medicine at Mount Sinai and published yesterday on Pub Med, a public database of biomedical topics maintained by the National Institutes of Health (study originally published in the December 12 issue of the journal Molecular Autism).
› Verified 7 days ago
News Archive
In people who have experienced a stroke, but who have no known history of coronary heart disease, beginning regular treatment with the cholesterol-lowering drug atorvastatin soon after the stroke can reduce the risk of recurrent stroke by 16 percent
At the largest green gathering in the South, chefs, foodies and restaurants have the opportunity to show off their organic food products to an audience deeply interested in green lifestyles and healthy, organic eating. At the 10th Annual Renewable Energy Roundup & Green Living Fair over 7500 people gather annually to explore products, organic food and technology that is sustainable, renewable, recyclable and geared to offering healthy, green-living choices.
Researchers at UCLA have identified a novel molecule in the brain that, after stroke, blocks the formation of new connections between neurons. As a result, it limits the brain's recovery. In a mouse model, the researchers showed that blocking this molecule-called ephrin-A5-induces axonal sprouting, that is, the growth of new connections between the brain's neurons, or cells, and as a result promotes functional recovery.
ChemAxon - a leading provider of cheminformatics software for the life sciences industry has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.
A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome, according to a pilot study conducted at the Icahn School of Medicine at Mount Sinai and published yesterday on Pub Med, a public database of biomedical topics maintained by the National Institutes of Health (study originally published in the December 12 issue of the journal Molecular Autism).
› Verified 7 days ago
Big Y Pharmacy #45 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 234 Tolland Tpke, Manchester, Connecticut 06040 Phone: (860) 646-4832 | |
Cvs Pharmacy #01910 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 260 N Main St, Manchester, Connecticut 06042 Phone: (860) 646-4510 | |
Cvs Pharmacy #04436 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 241 Middle Tpke W, Manchester, Connecticut 06040 Phone: (860) 533-1156 | |
Cvs Pharmacy #16597 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 125 Buckland Hills Dr, Manchester, Connecticut 06042 Phone: (860) 327-0083 | |
Cvs Pharmacy#10316 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1221 Main St, Manchester, Connecticut 06040 Phone: (860) 512-2256 |